Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine

被引:48
作者
Rompato, G
Ling, E
Chen, Z
Van Kruiningen, H
Garmendia, AE
机构
[1] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT 06268 USA
[2] Guanxi Vet Res Inst, Nanning, Peoples R China
关键词
porcine reproductive and respiratory syndrome virus (PRRSV); DNA vaccine; ORF-7; swine IL-2; swine IL-4;
D O I
10.1016/j.vetimm.2005.08.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study investigated the effect of swine interleukin 2 (IL-2) and swine interleukin 4 (IL-4) on the development of immune responses induced by a PRRSV-ORF7 DNA vaccine (phCMV-ORF7). The two cytokines were cloned separately in the eukaryotic expression vector phCMV, and delivered via gene gun as adjuvants for the DNA vaccine. Groups of 3-week-old certified PRRSV-free, castrated male, Yorkshire crossbred pigs, were vaccinated with or without the IL-2 or IL-4. The ensuing humoral and cellular immune responses were analyzed by a PRRSV-specific ELISA, and by an in vitro blastogenic response of peripheral blood mononuclear cells (PBMC) stimulated by viral antigen, respectively. The animals were boosted 21 days post-vaccination and challenged 28 days afterward. The virus loads post-challenge were measured by real time PCR. The group of swine receiving the vaccine plus IL-2 had significant virus-specific blastogenic responses 3 weeks after the vaccine-cytokine boost, when compared to those of the experimental pigs that received the vaccine plus IL-4, vaccine alone, unvaccinated controls or the pigs vaccinated with the DNA vaccine cloned in the reverse orientation (phCMV-ORF7(Rev)) None of the experimental swine had detectable specific antibodies against the virus during the vaccination phase. The virus load peak in vaccinated animals was delayed by about 72 It as compared to that of the control pigs (unvaccinated and vaccinated with the phCMV-ORF7Rev construct). Interestingly, animals that received the phCMV-ORF7 vaccine alone consistently had low virus loads throughout the study. These results demonstrate that IL-2 has a positive inductive effect on the activation of vaccine-induced virus-specific cellular immunity, while IL-4 appeared to have a suppressive effect. Our data also suggest that ORF7 may play a role in reducing the virus load in PRRSV infected animals. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 44 条
[1]   CYTOKINES - COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES [J].
ARAI, K ;
LEE, F ;
MIYAJIMA, A ;
MIYATAKE, S ;
ARAI, N ;
YOKOTA, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1990, 59 :783-836
[2]   NUCLEOTIDE AND DEDUCED AMINO-ACID-SEQUENCE OF PORCINE INTERLEUKIN 4 CDNA DERIVED FROM LAMINA PROPRIA LYMPHOCYTES [J].
BAILEY, M ;
PERRY, ACF ;
BLAND, PW ;
STOKES, CR ;
HALL, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1171 (03) :328-330
[3]   DNA vaccination of pigs with open reading frame 1-7 of PRRS virus [J].
Barfoed, AM ;
Blixenkrone-Moller, M ;
Jensen, MH ;
Botner, A ;
Kamstrup, S .
VACCINE, 2004, 22 (27-28) :3628-3641
[4]   Influence of routes and administration parameters on antibody response of pigs following DNA vaccination [J].
Barfoed, AM ;
Kirstensen, B ;
Dannemann-Jensen, T ;
Viuff, B ;
Botner, A ;
Kamstrup, S ;
Moller, MB .
VACCINE, 2004, 22 (11-12) :1395-1405
[5]   Enhancement of porcine natural killer cell activity by recombinant human and murine IL-12 [J].
Cho, DH ;
Lee, WJ ;
Halloran, PJ ;
Trinchieri, G ;
Kim, YB .
CELLULAR IMMUNOLOGY, 1996, 172 (01) :29-34
[6]  
Chow YH, 1998, J IMMUNOL, V160, P1320
[7]  
DEROSA DC, 1997, VETERINARMED, V44, P599
[8]   Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV) [J].
Duan, X ;
Nauwynck, HJ ;
Pensaert, MB .
VETERINARY MICROBIOLOGY, 1997, 56 (1-2) :9-19
[9]  
Feltquate DM, 1997, J IMMUNOL, V158, P2278
[10]   Rabies DNA vaccine in the horse: strategies to improve serological responses [J].
Fischer, L ;
Minke, J ;
Dufay, N ;
Baudu, P ;
Audonnet, JC .
VACCINE, 2003, 21 (31) :4593-4596